Literature DB >> 16730652

Spectroscopic diagnosis of chronic fatigue syndrome by visible and near-infrared spectroscopy in serum samples.

Akikazu Sakudo1, Hirohiko Kuratsune, Takanori Kobayashi, Seiki Tajima, Yasuyoshi Watanabe, Kazuyoshi Ikuta.   

Abstract

To investigate visible and near-infrared (Vis-NIR) spectroscopy enabling chronic fatigue syndrome (CFS) diagnosis, we subjected sera from CFS patients as well as healthy donors to Vis-NIR spectroscopy. Vis-NIR spectra in the 600-1100 nm region for sera from 77 CFS patients and 71 healthy donors were subjected to principal component analysis (PCA) and soft independent modeling of class analogy (SIMCA) to develop multivariate models to discriminate between CFS patients and healthy donors. The model was further assessed by the prediction of 99 masked other determinations (54 in the healthy group and 45 in the CFS patient group). The PCA model predicted successful discrimination of the masked samples. The SIMCA model predicted 54 of 54 (100%) healthy donors and 42 of 45 (93.3%) CFS patients of Vis-NIR spectra from masked serum samples correctly. These results suggest that Vis-NIR spectroscopy for sera combined with chemometrics analysis could provide a promising tool to objectively diagnose CFS.

Entities:  

Mesh:

Year:  2006        PMID: 16730652     DOI: 10.1016/j.bbrc.2006.05.074

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

Review 1.  Specific correlations between muscle oxidative stress and chronic fatigue syndrome: a working hypothesis.

Authors:  Stefania Fulle; Tiziana Pietrangelo; Rosa Mancinelli; Raoul Saggini; Giorgio Fanò
Journal:  J Muscle Res Cell Motil       Date:  2008-02-15       Impact factor: 2.698

2.  A candidate serum biomarker for bladder pain syndrome/interstitial cystitis.

Authors:  Daniel E Rubio-Diaz; Megan E Pozza; Jordan Dimitrakov; Jason P Gilleran; M Monica Giusti; Judith L Stella; Luis E Rodriguez-Saona; C A Tony Buffington
Journal:  Analyst       Date:  2009-04-16       Impact factor: 4.616

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.